These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 3449089)
21. Synthesis of N-{4-[(2,4-diamino-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid and N-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid as dual inhibitors of dihydrofolate reductase and thymidylate synthase and as potential antitumor agents. Gangjee A; Lin X; Kisliuk RL; McGuire JJ J Med Chem; 2005 Nov; 48(23):7215-22. PubMed ID: 16279780 [TBL] [Abstract][Full Text] [Related]
22. Conformational analysis of antineoplastic antifolates: the crystal structure of trimetrexate and the aminopterine derivative 4-[N-[(2,4-diamino-6-pteridinyl)methyl]amino]benzoic acid. Sutton PA; Cody V J Med Chem; 1987 Oct; 30(10):1843-8. PubMed ID: 2958629 [TBL] [Abstract][Full Text] [Related]
23. Molecular structures of 2,4-diaminopyrimidine antifolates with antineoplastic activity. Cody V; Zakrzewski SF J Med Chem; 1982 Apr; 25(4):427-30. PubMed ID: 7069721 [TBL] [Abstract][Full Text] [Related]
24. Quantitative structure-activity relationships of the inhibition of Pneumocystis carinii dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(X-phenyl)-s-triazines. Marlowe CK; Selassie CD; Santi DV J Med Chem; 1995 Mar; 38(6):967-72. PubMed ID: 7699713 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of Aryldihydro-s-triazines with antifolate activity II: Blood levels and their relevance to antineoplastic activity in rats. Upton RA; Ashley JJ; Ryan AJ J Pharm Sci; 1978 Mar; 67(3):310-4. PubMed ID: 641713 [TBL] [Abstract][Full Text] [Related]
26. Irreversible enzyme inhibitors. 196. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 1-(4-benzyloxy-3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine and bearing a terminal phenyl sulfonate group. Baker BR; Ashton WT J Med Chem; 1972 Sep; 15(9):945-7. PubMed ID: 5051014 [No Abstract] [Full Text] [Related]
27. Combined distance geometry analysis of dihydrofolate reductase inhibition by quinazolines and triazines. Ghose AK; Crippen GM J Med Chem; 1983 Jul; 26(7):996-1010. PubMed ID: 6864738 [TBL] [Abstract][Full Text] [Related]
28. 2,4-diamino-5-deaza-6-substituted pyrido[2,3-d]pyrimidine antifolates as potent and selective nonclassical inhibitors of dihydrofolate reductases. Gangjee A; Vasudevan A; Queener SF; Kisliuk RL J Med Chem; 1996 Mar; 39(7):1438-46. PubMed ID: 8691474 [TBL] [Abstract][Full Text] [Related]
29. Irreversible enzyme inhibitors. CLXXVI. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine by ether bridging to a terminal sulfonyl fluoride. Baker BR; Ashton WT J Med Chem; 1970 Nov; 13(6):1149-54. PubMed ID: 5479855 [No Abstract] [Full Text] [Related]
30. Structure determination of tetrahydroquinazoline antifolates in complex with human and Pneumocystis carinii dihydrofolate reductase: correlations between enzyme selectivity and stereochemistry. Cody V; Luft JR; Pangborn W; Gangjee A; Queener SF Acta Crystallogr D Biol Crystallogr; 2004 Apr; 60(Pt 4):646-55. PubMed ID: 15039552 [TBL] [Abstract][Full Text] [Related]
31. Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase inhibitors and antitumor agents: synthesis and biological activities of 2,4-diamino-5-methyl-6-[(monosubstituted anilino)methyl] pyrido[2,3-d]pyrimidines. Gangjee A; Adair O; Queener SF J Med Chem; 1999 Jul; 42(13):2447-55. PubMed ID: 10395486 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of bovine and rat liver dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(4-substituted-phenyl)-s-triazines. Hansch C; Dietrich SW; Fukunaga JY J Med Chem; 1981 May; 24(5):544-9. PubMed ID: 7241512 [No Abstract] [Full Text] [Related]
33. Crystal structures of Escherichia coli dihydrofolate reductase complexed with 5-formyltetrahydrofolate (folinic acid) in two space groups: evidence for enolization of pteridine O4. Lee H; Reyes VM; Kraut J Biochemistry; 1996 Jun; 35(22):7012-20. PubMed ID: 8679526 [TBL] [Abstract][Full Text] [Related]
34. Conformationally restricted analogues of trimethoprim: 2,6-diamino-8-substituted purines as potential dihydrofolate reductase inhibitors from Pneumocystis carinii and Toxoplasma gondii. Gangjee A; Vasudevan A; Queener SF J Med Chem; 1997 Sep; 40(19):3032-9. PubMed ID: 9301665 [TBL] [Abstract][Full Text] [Related]
35. Irreversible enzyme inhibitors. CLXXIX. Active-site-directed irreversible enzyme inhibitors of dihydrofolate reductase from 1-(3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine with oxyamide bridges to a terminal sulfonyl fluoride. Baker BR; Ashton WT J Med Chem; 1970 Nov; 13(6):1165-70. PubMed ID: 5479858 [No Abstract] [Full Text] [Related]
36. Irreversible enzyme inhibitors. 178. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 1-(4-benzyloxy-3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine with a terminal sulfonyl fluoride. Baker BR; Ashton WT J Med Chem; 1970 Nov; 13(6):1161-5. PubMed ID: 5479857 [No Abstract] [Full Text] [Related]
37. Structural studies on bio-active compounds. Part 9. 2,4-Diamino-6-azidoquinazoline hydrochloride. Schwalbe CH; King ME; Wong KP; Lambert PA; Bliss A; Stevens MF Anticancer Drug Des; 1987 Dec; 2(3):289-96. PubMed ID: 3449092 [TBL] [Abstract][Full Text] [Related]
38. Design of dihydrofolate reductase inhibitors from X-ray crystal structures. Roth B Fed Proc; 1986 Nov; 45(12):2765-72. PubMed ID: 3533642 [TBL] [Abstract][Full Text] [Related]
39. Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations. Piper JR; Johnson CA; Krauth CA; Carter RL; Hosmer CA; Queener SF; Borotz SE; Pfefferkorn ER J Med Chem; 1996 Mar; 39(6):1271-80. PubMed ID: 8632434 [TBL] [Abstract][Full Text] [Related]